Other Opioid Peptides

Product #

Description

Biochem/physiol Actions

Add to Cart

A9471 Acetyl-Arg-Tyr-Tyr-Arg-Ile-Lys Amide >97% (HPLC), solid  
C6352 CTAP ≥95% Selective μ-opioid receptor antagonist.
P5296 CTOP ≥97% (HPLC) D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) inhibits acute morphine-induced hypermotility and analgesic effect of morphine in a dose-dependent manner in vivo.
T0675 [D-Ala2]-Deltorphin II ≥97% (HPLC) Selective δ2 opioid receptor agonist
N9412 6β-Naltrexol hydrate ≥96% (HPLC), powder Neutral antagonist of the μ-opioid receptor. A reduction of withdrawal effects associated with neutral μ-opioid receptor antagonists may offer advantages in treating opioid overdose and addiction.
N9905 Neuropeptide SF human ≥92% (HPLC), solid Anti-opiate neuropeptide implicated in pain modulation.
N213 [Phe1-ψ(CH2-NH)-Gly2]-Nociceptin Fragment 1-13 amide lyophilized powder Selective ORL1 opioid receptor antagonist at peripheral receptors. It functions as a partial agonist at central ORL1 receptors.
N9908 [Phe1-ψ(CH2-NH)-Gly2]-Nociceptin Fragment 1-13 amide >95% Selective ORL1 opioid receptor antagonist at peripheral receptors. It functions as a partial agonist at central ORL1 receptors.
O4011 Orphanin FQ ≥95% (HPLC) Endogenous agonist at opioid receptor-like1 (ORL1) receptors.
T5830 Trap-101 hydrochloride ≥98% (HPLC), powder Trap-101 Hydrochloride is a nociceptin/orphanin FQ peptide (NOP) receptor blocker. Trap-101 acts as an inverse agonist. Trap-101 had been found to be an effective NOP receptor antagonist both in vitro and in vivo, with equivalent potency to J113397.
U5635 UFP-101 trifluoroacetate salt ≥98% (HPLC), powder UFP-101 is a potent antagonist of nociceptin/orphanin FQ receptor; ORL1